Get started
Author

Tsedenia Bezabeh

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
2021 · Christine G. Lee, Brandy Heckman-Stoddard, et al. · Diabetes Care · 100
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures
2020 · Andrea M. Kriska, Bonny Rockette-Wagner, et al. · Diabetes Care · 72
PDF
Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience
2022 · Neil H. White, Qing Pan, et al. · Diabetes Care · 36
PDF
The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact
2025 · Jill P. Crandall, Dana Dabelea, et al. · Diabetes Care · 34
PDF
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program
2019 · Zsu-Zsu Chen, Jinxi Liu, et al. · Diabetes · 26
PDF
Association of Metformin With the Development of Age-Related Macular Degeneration
2022 · Amitha Domalpally, Samuel A. Whittier, et al. · JAMA Ophthalmology · 25
Integrase Strand Transfer Inhibitors and Weight Gain in Children and Youth With Perinatal Human Immunodeficiency Virus in the DC Cohort
2021 · Wei Li A Koay, Sahera Dirajlal-Fargo, et al. · Open Forum Infectious Diseases · 21
PDF
Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors
2019 · Jordi Merino, Kathleen A. Jablonski, et al. · Diabetes · 21
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH
2023 · Josephine H. Li, Laura N. Brenner, et al. · Diabetologia · 20
PDF
Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)
2022 · Josephine H. Li, James A. Perry, et al. · Diabetes · 19
PDF
Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks
2025 · Emily Kobayashi, Nathaniel J. Linden-Santangeli, et al. · Diabetes Care · 10
Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure
2024 · Christine G. Lee, Adam Ciarleglio, et al. · Diabetes Care · 10
PDF
Characterization of HIV Risk Behaviors and Clusters Using HIV-Transmission Cluster Engine Among a Cohort of Persons Living with HIV in Washington, DC
2021 · Brittany Wilbourn, Brittani Saafir-Callaway, et al. · AIDS Research and Human Retroviruses · 9
Risk of Severe COVID-19 Disease and the Pandemic’s Impact on Service Utilization Among a Longitudinal Cohort of Persons with HIV-Washington, DC
2022 · Anne K. Monroe, Jiayang Xiao, et al. · AIDS and Behavior · 8
PDF
The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)
2022 · Marissa M. Shams-White, Ashley H. Tjaden, et al. · BMC Nutrition · 7
PDF
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience
2022 · Neil H. White, Qing Pan, et al. · Diabetes Care · 7
PDF
Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes
2026 · Marcel E. Salive, Ashley H. Tjaden, et al. · JAMA · 5
Site assessment survey to assess the impact of the COVID-19 pandemic on HIV clinic site services and strategies for mitigation in Washington, DC
2023 · Nicole Barish, Shannon Barth, et al. · BMC Health Services Research · 4
PDF
Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025 · William H. Herman, Adam Ciarleglio, et al. · Diabetes Care · 3
Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts
2021 · Anne K Monroe, Matthew E Levy, et al. · Open Forum Infectious Diseases · 3
PDF
Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS)
2025 · Ashley H. Tjaden, Barbara H. Braffett, et al. · Diabetes Care · 2
The Association of Mental Health and Substance Use With Retention in HIV Care Among Black Women in Washington, District of Columbia
2024 · Bianca Stewart, Morgan Byrne, et al. · Women s Health Issues · 2
Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study
2025 · William C. Knowler, Qing Pan, et al. · Diabetes Care · 1
Improvements in Virologic Control Among PWH Over Time: Narrowing the Gap Between Those With and Without STIs
2022 · Hana Akselrod, Morgan Byrne, et al. · AIDS and Behavior · 1
PDF
Short Communication:Outcomes of Dual Versus Triple Antiretroviral Drug Regimens Among Virally Suppressed Adults in the DC Cohort
2022 · Wei Li Adeline Koay, Jiayang Xiao, et al. · AIDS Research and Human Retroviruses · 1
Works count: 27
Citation count: 447
H-index: 10
I10-index: 12
Year
Topic
Type